Jennifer Zachary's Net Worth
$22.5 Million
Who is Jennifer Zachary?
Jennifer Zachary has an estimated net worth of $22.5 Million. This is based on reported shares across multiple companies, which include Merck & Co., Inc., and REGENXBIO Inc..
SEC CIK
Jennifer Zachary's CIK is 0001737231
Past Insider Trading and Trends
2022 was Jennifer Zachary's most active year for acquiring shares with 7 total transactions. Jennifer Zachary's most active month to acquire stocks was the month of April. 2022 was Jennifer Zachary's most active year for disposing of shares, totalling 5 transactions. Jennifer Zachary's most active month to dispose stocks was the month of April. 2023 saw Jennifer Zachary paying a total of $5,944,967.72 for 153,939 shares, this is the most they've acquired in one year. In 2022 Jennifer Zachary cashed out on 313,902 shares for a total of $16,422,892.71, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Merck & Co., Inc. (MRK) Snapshot price: $117.36
EVP, General Counsel
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 30
| |||
Form 4
| -50.87% | -30.08K |
$107.04 | -$4,593,558.43 | 29.06K |
Feb 2
| |||
Form 4
| +65.00% | 23.3K |
$119.43 | $2,782,480.14 | 59.14K |
Jan 22
| |||
Form 4
| -35.27% | -19.14K |
$117.59 | -$2,250,834.21 | 35.13K |
May 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 2
| |||
Form 4
|
—
|
0
|
$79.61 | -$3,555,328.85 | 53.92K |
Feb 3
| |||
Form 4
| +40.82% | 15.63K |
$109.88 | $1,717,534.28 | 53.92K |
Jan 23
| |||
Form 4
| -30.39% | -16.61K |
$99.38 | -$16,422,892.71 | 38.04K |
Oct 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 3
| |||
Form 4
| +52.63% | 18.42K |
$73.51 | $1,354,054.20 | 53.42K |
Feb 24
| |||
Form 4
| +9.38% | 2.93K |
$75.98 | $222,545.42 | 34.14K |
May 4
| |||
Form 4
| +358.60% | 24.2K |
$72.62 | $1,757,331.38 | 30.95K |
Feb 26
| |||
Form 4
| +78.79% | 2.93K |
$77.67 | $227,495.43 | 6.65K |
May 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 1
| |||
Form 4
|
∞
| 3.62K |
$80.00 | -$172,320.00 | 3.62K |
May 3 - May 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 4
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
REGENXBIO Inc. (RGNX) Snapshot price: $11.48
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +50.39% | 4.79K |
—
|
—
| 14.3K |
May 31
| |||
Form 4
| +57.91% | 3.49K |
—
|
—
| 9.51K |
Jun 2
| |||
Form 4
|
∞
| 6.02K |
—
|
—
| 6.02K |
Jun 3
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||